Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

337 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A new effective four-drug combination of CCNU (1-[2-chloroethyl]-3-cyclohexyl-1-nitrosourea) (NSC-79038), vinblastine, prednisone, and procarbazine for the treatment of advanced Hodgkin's disease.
Cooper MR, Pajak TF, Nissen NI, Stutzman L, Brunner K, Cuttner J, Falkson G, Grunwald H, Bank A, Leone L, Seligman BR, Silver RT, Weiss RB, Haurani F, Blom J, Spurr CL, Glidewell OJ, Gottlieb AJ, Holland JF. Cooper MR, et al. Among authors: weiss rb. Cancer. 1980 Aug 15;46(4):654-62. doi: 10.1002/1097-0142(19800815)46:4<654::aid-cncr2820460405>3.0.co;2-a. Cancer. 1980. PMID: 7397630 Clinical Trial.
A randomized combined modality trial in small cell carcinoma of the lung: comparison of combination chemotherapy-radiation therapy versus cyclophosphamide-radiation therapy effects of maintenance chemotherapy and prophylactiv whole brain irradiation.
Maurer LH, Tulloh M, Weiss RB, Blom J, Leone L, Glidewell O, Pajak TF. Maurer LH, et al. Among authors: weiss rb. Cancer. 1980 Jan 1;45(1):30-9. doi: 10.1002/1097-0142(19800101)45:1<30::aid-cncr2820450107>3.0.co;2-6. Cancer. 1980. PMID: 6243242 Clinical Trial.
Clinical trial of VP 16--213 (NSC 141540) I.V. twice weekly in advanced neoplastic disease: a study by the Cancer and Leukemia Group B.
Nissen NI, Pajak TF, Leone LA, Bloomfield CD, Kennedy BJ, Ellison RR, Silver RT, Weiss RB, Cuttner J, Falkson G, Kung F, Bergevin PR, Holland JF. Nissen NI, et al. Among authors: weiss rb. Cancer. 1980 Jan 15;45(2):232-5. doi: 10.1002/1097-0142(19800115)45:2<232::aid-cncr2820450206>3.0.co;2-f. Cancer. 1980. PMID: 6985831 Clinical Trial.
Postsurgical adjuvant chemotherapy of stage II breast carcinoma with or without crossover to a non-cross-resistant regimen: a Cancer and Leukemia Group B study.
Perloff M, Norton L, Korzun AH, Wood WC, Carey RW, Gottlieb A, Aust JC, Bank A, Silver RT, Saleh F, Canellos GP, Perry MC, Weiss RB, Holland JF. Perloff M, et al. Among authors: weiss rb. J Clin Oncol. 1996 May;14(5):1589-98. doi: 10.1200/JCO.1996.14.5.1589. J Clin Oncol. 1996. PMID: 8622076 Clinical Trial.
337 results